Home » Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says
Idenix Seeks Partner for Hepatitis C Combination Drug, CEO Renaud Says
Idenix Pharmaceuticals, the developer of an experimental hepatitis C drug, is in talks to find a partner to create a combination treatment to fight the virus, CEO Ron Renaud said.
Bloomberg
Bloomberg
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May